Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (603)	12/19/1997 1:52:00 PM
From: Czechsinthemail	Read Replies (3) \| Respond to of 887

richard, With DEPO's price already starting to inch back up without any good news, the boost from any positive news could be substantial. If DepoCyt for solid tumors comes down to a small numbers problem that can be remedied by supplemental data and the data are stronger for lymphoma and leukemia, DepoCyt could experience a dramatic reincarnation. At this point, with all the bad news out and most of the momentum players gone, you have a balance of stronger hands holding shares that are likely to become more rather than less attractive. Baird